CFDE Data Portal | Search NR2F1

	Label	Description
	NR2F1 Gene (Entity type)	ENSG00000175745 - nuclear receptor subfamily 2 group F member 1
	NR2F1-AS1 Gene (Entity type)	ENSG00000237187 - NR2F1 regulatory antisense RNA 1
	NR2F1 associations Collection (Entity type)	Associations for NR2F1_associations
	NR2F1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	NR2F1-AS1 associations Collection (Entity type)	Associations for NR2F1-AS1_associations
	GSE114492 GSE153671 KMT2D inhibition 6 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 7 V 9 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE216273,GSE216292 14 V 6 PALBOCICLIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE135350 2 V 4 DEXAMETHASONE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE158632 3 V 5 OXYQUINOLINE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

NR2F1

ENSG00000175745 - nuclear receptor subfamily 2 group F member 1

NR2F1-AS1

ENSG00000237187 - NR2F1 regulatory antisense RNA 1

NR2F1 associations

Associations for NR2F1_associations

NR2F1 associations.tsv

A file from IDG as part of the Harmonizome project

NR2F1-AS1 associations

Associations for NR2F1-AS1_associations

GSE114492 GSE153671 KMT2D inhibition 6 v 8 human dn

A Gene Set from LINCS

GSE216043 7 V 9 CISPLATIN HUMAN DN

A Gene Set from LINCS

GSE216273,GSE216292 14 V 6 PALBOCICLIB HUMAN DN

A Gene Set from LINCS

GSE135350 2 V 4 DEXAMETHASONE HUMAN DN

A Gene Set from LINCS

GSE158632 3 V 5 OXYQUINOLINE HUMAN DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.